Logo Logo

Category Archives: "INforMS"

  1. Home
  2. INforMS
  3. Page 33
May 28, 2014
Biogen Idec announces official partnership with Sailing Sclerosis’ “Oceans of Hope”
INforMS, Partners
Biogen Idec Announces Official Partnership with Sailing Sclerosis Oceans of Hope to Globally Change Perceptions of MS Wednesday, May [...]
Elizabeth Porco
Read More
...23
0
May 24, 2014
Genzyme recognizes sixth annual World MS Day
INforMS, MS Community, Partners
Genzyme Recognizes Sixth Annual World MS Day - Company Supporting Wide Range of Programs to Help Improve the Lives of People Living with [...]
Elizabeth Porco
Read More
...23
0
May 23, 2014
CHMP adopts positive opinion for PLEGRIDY as a treatment for multiple sclerosis in the EU
INforMS, Partners
CHMP Adopts Positive Opinion for PLEGRIDY™ (Peginterferon Beta-1a) as a Treatment for Multiple Sclerosis in the European Union Friday, [...]
Elizabeth Porco
Read More
...21
0
May 13, 2014
Opexa reaches enrollment target in phase IIb trial of personalizedimmunotherapy for SPMS
INforMS
Opexa Reaches Enrollment Target in Phase IIb Trial of Personalized Immunotherapy for Secondary Progressive Multiple [...]
Elizabeth Porco
Read More
...24
0
May 08, 2014
Teva announces COPAXONE recognized as “Brand of the Year” by Pharm Exec Magazine
INforMS, Partners
Teva announces COPAXONE® recognized as Brand of the Year by Pharmaceutical Executive Magazine JERUSALEM--(BUSINESS WIRE)--May 8, [...]
Elizabeth Porco
Read More
...23
0
May 01, 2014
New TYSABRI analysis shows improved walking speed in significant number of multiple sclerosis patients
INforMS, Partners
New TYSABRI® Analysis at AAN Annual Meeting Shows Improved Walking Speed in Significant Number of MS Patients Thursday, May 1, 2014 [...]
Elizabeth Porco
Read More
...24
0
Apr 30, 2014
New data reinforce efficacy of TECFIDERA in multiple sclerosis patients with high disease activity
INforMS, Partners
New Data Reinforce Efficacy of TECFIDERA® (Dimethyl Fumarate) in MS Patients with High Disease Activity Wednesday, April 30, 2014 7:30 [...]
Elizabeth Porco
Read More
...24
0
Apr 30, 2014
Slowing of brain atrophy sustained at three years in patients treated with Lemtrada
INforMS, Partners
Slowing of Brain Atrophy and Reductions in New Multiple Sclerosis Lesions Sustained at Three Years in Patients Treated with Genzyme’s [...]
Elizabeth Porco
Read More
...23
0
Apr 30, 2014
Genzyme announces multi-year multiple sclerosis research collaboration with academic medical center
INforMS, Partners
Genzyme Announces Multi-Year Multiple Sclerosis Research Collaboration with Leading Academic Medical Center Wednesday, April 30, 2014 [...]
Elizabeth Porco
Read More
...18
0
Apr 19, 2014
Teva announces supreme court denial of request for interim relief to stay
INforMS, Partners
Teva Announces Supreme Court Denial of Request for Interim Relief to Stay Court of Appeals Ruling for Copaxone® Patent Due to the [...]
Elizabeth Porco
Read More
...23
0
  • (201) 487-1050
  • 3 University Plz Dr Ste 116, Hackensack, NJ 07601
  • info@mscare.org

CMSC provides leadership in clinical research and education; develops vehicles to share information and knowledge among members; disseminates information to the health care community and to persons affected by MS.

Contact Us
Contact Us
I have a question about
First
Last

Feel Free To contact Us
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam molestie, tellus id pellen tesque feugiat, sem sem cursus orci, a placerat ante ante nec massa. consectetuer adipiscing elit.

+1-222-333-4444

New York, NY 10123 USA

Mon - Sat 9:00 AM